KISHOR ZINZUVADIA: Open Payments
NPI 1275582165 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75,006 in 138 payments from 10 companies in 2025. Trend: 2023 $109,974 · 2024 $137,649 · 2025 $75,006
Speaker / faculty: $66,404Food & beverage: $4,172Travel & lodging: $3,758Consulting: $560Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 53 | $61,425 |
| ABBVIE INC. | 21 | $10,480 |
| E.R. Squibb & Sons, L.L.C. | 26 | $1,878 |
| Axsome Therapeutics, Inc. | 8 | $471 |
| Alkermes, Inc. | 15 | $321 |
| Bausch Health US, LLC | 8 | $166 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Luye Pharma (USA) Ltd. | 2 | $55 |
| Lundbeck LLC | 1 | $27 |
Products named: UZEDY, AUSTEDO XR, VRAYLAR, COBENFY, Auvelity, ARISTADA, APLENZIN, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
